Mesirow Financial Investment Management, Inc. Chembio Diagnostics, Inc. Transaction History

Mesirow Financial Investment Management, Inc.

  • $4.3 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 09, 2020
SELL
$3.94 - $5.76 $151,225 - $221,080
-38,382 Closed
0 $0
Q3 2019

Oct 30, 2019
SELL
$4.84 - $7.25 $1,916 - $2,871
-396 Reduced 1.02%
38,382 $235,000
Q2 2019

Jul 12, 2019
BUY
$5.56 - $7.85 $215,605 - $304,407
38,778 New
38,778 $219,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email